Waycross Partners, LLC Eli Lilly & CO Transaction History

Waycross Partners, LLC

$723 Million
Q3 2024

A detailed history of Waycross Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Waycross Partners, LLC holds 5,000 shares of LLY stock, worth $3.92 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

5,000

Previous 5,000 -0.0%

Holding current value

$3.92 Million

Previous $4.53 Million 2.14%

% of portfolio

0.61%

Previous 0.69%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$724.87 - $909.04 $724,870 - $909,040	-1,000 Reduced 16.67%	5,000 $4.53 Million
Q1 2024 May 02, 2024	SELL	$592.2 - $792.28 $296,100 - $396,140	-500 Reduced 7.69%	6,000 $4.67 Million
Q4 2023 Feb 05, 2024	SELL	$525.19 - $619.13 $1.26 Million - $1.49 Million	-2,400 Reduced 26.97%	6,500 $3.79 Million
Q3 2023 Nov 13, 2023	SELL	$434.7 - $599.3 $1.28 Million - $1.77 Million	-2,950 Reduced 24.89%	8,900 $4.78 Million
Q2 2023 Jul 26, 2023	SELL	$350.74 - $468.98 $8.35 Million - $11.2 Million	-23,806 Reduced 66.77%	11,850 $5.56 Million
Q1 2023 May 04, 2023	BUY	$310.63 - $364.82 $1.59 Million - $1.87 Million	5,121 Added 16.77%	35,656 $12.2 Million
Q4 2022 Feb 06, 2023	BUY	$321.55 - $374.67 $4 Million - $4.66 Million	12,425 Added 68.61%	30,535 $11.2 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $1.21 Million - $1.38 Million	4,095 Added 29.22%	18,110 $5.86 Million
Q2 2022 Aug 09, 2022	SELL	$278.73 - $327.27 $984,474 - $1.16 Million	-3,532 Reduced 20.13%	14,015 $4.54 Million
Q1 2022 Apr 29, 2022	BUY	$234.69 - $291.66 $166,160 - $206,495	708 Added 4.2%	17,547 $5.03 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $615,864 - $764,290	2,739 Added 19.43%	16,839 $4.65 Million
Q3 2021 Nov 10, 2021	SELL	$221.6 - $272.71 $750,559 - $923,668	-3,387 Reduced 19.37%	14,100 $3.26 Million
Q2 2021 Aug 17, 2021	SELL	$180.55 - $233.54 $5.9 Million - $7.63 Million	-32,681 Reduced 65.14%	17,487 $4.01 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $6.24 Million - $8.07 Million	34,555 Added 221.32%	50,168 $118 Million
Q1 2021 May 12, 2021	BUY	$164.32 - $212.72 $2.57 Million - $3.32 Million	15,613 New	15,613 $2.92 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $744B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Waycross Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Waycross Partners, LLC with notifications on news.

Account

Waycross Partners, LLC Eli Lilly & CO Transaction History